FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

21525211000001107: Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71529701000001114 Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71529801000001117 Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Is a Oseltamivir 30mg/5ml oral suspension sugar free 65 ml true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has AMP Tamiflu 6mg/ml oral suspension (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has specific active ingredient Oseltamivir phosphate true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Oseltamivir true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tamiflu 6mg/ml oral suspension (Roche Products Ltd) 65 ml Has basis of strength substance Oseltamivir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start